Most studies of IBD are conducted on humans where risk factors have been identified, including nucleotide-binding oligomerization domain2 (NOD2), a gene revealed by GSEA analysis as being enriched in diarrhoea-susceptible sheep (Al Nabhani et al. 2017). Here, NOD2 is linked to inflammatory bowel disease.